Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion type Assertion NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_head.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion description "[Strong suppression of both, NPRL2 and RBSP3 was seen in 100% of cases already at Stage I of squamous cell carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_provenance.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion evidence source_evidence_literature NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_provenance.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion SIO_000772 20193080 NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_provenance.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion wasDerivedFrom befree-20140225 NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_provenance.
- NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_assertion wasGeneratedBy ECO_0000203 NP402720.RAeJ4VM1q0lLCaN8UFu5jkGMq4d94tYV8vvhUk19L4bns130_provenance.